Syringin inhibits insulin resistance through the PI3K/AKT pathway
By: Haitao Wang, Jianjian Han, Lu Yun and Xiaolei Wang
Authors
Qingdao Central Hospital University of Health and Rehabilitation Sciences, Qingdao, China
Jianjian Han
Qingdao Central Hospital University of Health and Rehabilitation Sciences, Qingdao, China
Lu Yun
Qingdao Central Hospital University of Health and Rehabilitation Sciences, Qingdao, China
Xiaolei Wang
Qingdao Central Hospital University of Health and Rehabilitation Sciences, Qingdao, China
Language: English
Accepted on: Sep 1, 2026
Published on: Oct 13, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Haitao Wang, Jianjian Han, Lu Yun, Xiaolei Wang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.